Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: Retrieve TM
Active ingredients: tretinoin
What it is used for
ReTrieve is indicated for the adjunctive treatment of dry photoaged skin and related conditions.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Topical
- Store below 25 degrees Celsius
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Smooth off-white to pale yellow cream
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient tretinoin
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
ReTrieve Cream - myDr.com.au
ReTrieve Cream - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Oocyte Retrieval | myVMC
Oocyte retrieval is the process of collecting mature eggs directly from a woman's ovaries before they are released from ovarian follicles.
Read more on myVMC – Virtual Medical Centre website
Ovarian stimulation in IVF treatment information | my VMC
Ovarian stimulation is a component of in vitro fertilisation used to stimulate maturation of eggs (oocytes) so that they can be retrieved from the ovaries.
Read more on myVMC – Virtual Medical Centre website
Semen Analysis (Sperm Count Testing) | myVMC
Semen analysis testingassesses a man's fertilitythrough examinination ofa sample of freshly retrieved semen under a microscope to determine volume and quality of the sperm.
Read more on myVMC – Virtual Medical Centre website
Reflux in older children - Reflux Infants Support Association Inc
Many reflux children improve through their first 12-18 months; others continue to suffer. There's increasing recognition that it can continue in older kids.
Read more on Reflux Infants Support Association website
Infertility Treatments (Assisted Reproductive Technologies; ARTs) | myVMC
Treatment options for infertility include lifestyle changes, surgical treatment, pharmacological treatment and assisted reproductive technologies (ARTs).
Read more on myVMC – Virtual Medical Centre website
How Reflux presents - Reflux Infants Support Association Inc
Caring for a baby or child who suffers from gastro-oesophageal reflux can be extremely stressful and you may find yourself on an emotional rollercoaster ride. You may not realise your experience and emotions can be perfectly normal for your situation but this is where the Reflux Infants Support Association (RISA) Inc can help.
Read more on Reflux Infants Support Association website
Cryopreservation | myVMC
Cryopreservation refers to the process of freezing human gametes, embryos and/or ovarian or testicular tissues, with a view to thawing the cells for use in assisted reproduction treatments.
Read more on myVMC – Virtual Medical Centre website
Nutrition for Men Dietitians Association of Australia
Nutrition for Men Did you know mens nutrition needs change at different times of the lifespan? Good nutrition is essential for peak performance, and a healthy diet should meet your physical needs, fit with your lifestyle, and be enjoyable
Read more on Dietitians Association of Australia website
Intracytoplasmic Sperm Injection (ICSI) | myVMC
Intracytoplasmic sperm injection is a technique used to treat male factor infertility which involves injecting a single sperm into the centre of a mature oocyte under a microscope.
Read more on myVMC – Virtual Medical Centre website
Top results
Electronic retrieval of health information by health professionals | Cochrane
Read more on Cochrane (Australasian Centre) website
Pain relief for women undergoing oocyte retrieval for assisted reproduction | Cochrane
Conscious sedation and analgesia are methods used to relieve pain during surgery to retrieve eggs from the ovaries as part of in vitro fertilisation procedures. There have been concerns that the drugs used for sedation and pain relief may have an adverse effect on pregnancy rates. This review identified 21 randomised controlled trials, involving 2974 women, comparing the effects of five different methods of conscious sedation and pain relief including general anaesthesia. We found insufficient evidence to support any one method as being superior to others in terms of pain relief or pregnancy outcomes. The mainstay of pain relief is the use of opioid drugs.Most of the methods seemed to work well and the effect was usually enhanced by addition of another method such as pain relief with paracervical block, which involves a local anaesthetic agent being injected in the cervix prior to egg retrieval. Women reported a high degree of acceptability and satisfaction associated with the various methods that were assessed in this review. Evidence was generally of low quality, mainly due to poor reporting of methods, small sample sizes and inconsistency between the trials. As women vary in their experience of pain and in coping strategies, the optimal method may be individualised.
Read more on Cochrane (Australasian Centre) website
Follicular flushing during oocyte retrieval in assisted reproductive technology | Cochrane
Flushing of the follicles during egg collection is not useful, as it prolongs the operating time and increases the need for pain relief without increasing the chances of a pregnancy or increasing the number of eggs recovered.
Read more on Cochrane (Australasian Centre) website
No evidence to support or refute the use of ischaemic preconditioning in liver transplantation | Cochrane
Ischaemic preconditioning is a mechanism for reducing organ ischaemia reperfusion injury by a brief period of organ ischaemia, ie, decrease the injury caused by return of blood supply to the organ after a period of decreased or absent blood supply by exposing the organ to shorter periods of decreased blood supply. There is considerable controversy regarding whether ischaemic preconditioning during donor liver retrieval has beneficial effect on the outcome of liver transplantation. This systematic review includes five randomised clinical trials assessing the advantages and disadvantages of ischaemic preconditioning during donor hepatectomy for liver transplant recipients. In four trials, 270 cadaveric liver donor retrievals were randomised; 131 to ischaemic preconditioning and 139 to no ischaemic preconditioning; and in one trial, 15 living donor liver retrievals were randomised; 10 to ischaemic preconditioning and 5 to no ischaemic preconditioning. All the trials were high bias-risk trials. There was no statistically significant difference in mortality, initial poor function, re-transplant, primary graft non-function, or in any other outcome other than enzyme markers of liver injury, which was in different directions in different trials. There is currently no evidence to support or refute the use of ischaemic preconditioning in donor liver retrievals. Further studies are necessary to identify the optimal ischaemic preconditioning stimulus.
Read more on Cochrane (Australasian Centre) website
Homeopathy for ADHD | Cochrane
This review aimed to assess the evidence for homeopathy as an intervention for attention deficit/hyperactivity disorder. Four trials were retrieved and assessed with mixed results. Overall the results of this review found no evidence of effectiveness for homeopathy for the global symptoms, core symptoms or related outcomes of attention deficit/hyperactivity disorder.
Read more on Cochrane (Australasian Centre) website
Ovarian cyst aspiration and IVF outcomes | Cochrane
Cochrane authors investigated the effectiveness and safety of cyst aspiration before ovarian stimulation versus a conservative approach (no aspiration) in women undergoing In vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). Our primary outcomes were live birth rate and adverse events. We also assessed pregnancy rates, number of follicles recruited, and number of oocytes retrieved.
Read more on Cochrane (Australasian Centre) website
Interventions for women with endometrioma prior to assisted reproductive technology | Cochrane
Endometriomata are a form of ovarian endometriosis, classified as cysts within the ovaries. They are a common cause of subfertility and pelvic pain. This review aimed to determine which treatment approach was better for women with subfertility and endometriomata who were undergoing assisted reproductive technology (ART). Four trials were identified. A gonadotropin-releasing hormone (GnRH) agonist showed a positive treatment effect on the ovarian response to controlled ovarian hyperstimulation (COH) and the number of mature oocytes retrieved compared to GnRH antagonist. The evidence for surgery was limited but aspiration was associated with a greater ovarian response than expectant management (a wait and see approach). Further randomised controlled trials of interventions for the management of endometrioma in women undergoing ART are required.
Read more on Cochrane (Australasian Centre) website
No evidence to support or refute elective surgery for benign liver tumours | Cochrane
The most common benign liver tumours include cavernous haemangioma, focal nodular hyperplasia, and hepatic adenoma. The majority of patients are asymptomatic, and no treatment is indicated. The natural history of haemangioma and focal nodular hyperplasia is typically uneventful whereas that of hepatic adenoma can be complicated by life-threatening conditions, such as rupture and haemorrhage. For these complications or when a definite histologic diagnosis is needed, surgery is advisable. However, in clinical practice there is a wide variation concerning the use of elective surgery (ie, surgery performed before complications have developed). No randomised clinical trials were identified for this systematic review, but 31 case series without a proper control group were retrieved. Accordingly, there is no evidence to support or refute elective surgery for benign liver tumours.
Read more on Cochrane (Australasian Centre) website
Autologous chondrocyte implantation for full thickness articular cartilage defects of the knee | Cochrane
A layer of cartilage covering the knee joint surfaces acts to protect the joint and reduce friction. Damage to the cartilage (articular surface) can decrease mobility of the joint and cause pain on movement. Continuing deterioration of the surface may lead to osteoarthritis. Treatments for damaged cartilage include relieving symptoms, surgically cleaning up the joint, or surgically re-establishing the cartilage layer. The latter is done using marrow stimulation techniques (such as microfracture), mosaicplasty (also known as osteochondral cylinder transplantation), and more recently with implantation of healthy cartilage cells (chondrocytes). In the technique of autologous chondrocyte implantation (ACI), a small piece of cartilage is retrieved from the knee joint. This piece is brought to a laboratory where it is digested to free the chondrocyte cells; these cells are subsequently cultured in a culture media in order to expand the numbers of cells. Then, with a second surgery, the cells are placed into the joint defect in an effort to produce a tissue that substitutes the normal cartilage.
Read more on Cochrane (Australasian Centre) website
Use of fibrinogen concentrate in patients with bleeding | Cochrane
Fibrinogen is a natural blood protein involved in the coagulation process. Bleeding decreases the blood level, and low levels of this protein may increase bleeding even further, thereby increasing morbidity and mortality. Fibrinogen concentrate is widely used instead of traditional sources of fibrinogen, such as the blood products fresh frozen plasma and cryoprecipitate (a pooled concentrated plasma product), especially in some countries, despite the lack of adequate knowledge derived from previous research to support such an approach. In the present Cochrane systematic review, we set out to assess the benefits and harms of fibrinogen concentrate in patients with bleeding. We searched the databases to August 2013, we identified six randomized trials in cardiac and elective surgical settings that compared fibrinogen concentrate (248 participants) with placebo/other sources or no treatment. Additionally, we found 12 ongoing trials, but we were unable to retrieve any data from them. We could not identify beneficial effects of fibrinogen concentrate on patient survival. In our predefined outcomes, we identified a reduced proportion of patients requiring donor blood transfusion. We could not identify reduced blood loss or any harms or adverse events caused by treatment with fibrinogen concentrate. However, all trials were of low quality and were small, so evidence in support of fibrinogen concentrate in patients with bleeding remains weak.
Read more on Cochrane (Australasian Centre) website
